Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (4) , 721-725
- https://doi.org/10.1016/0360-3016(92)90511-f
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine : effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069Radiotherapy and Oncology, 1989
- Effects of the manipulation of oxyhemoglobin status by BW121 on tumor thermosensitivity and on blood flow in tumor and normal tissues in miceInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Induction of hypoxia in normal and malignant tissues by changing the oxygen affinity of hemoglobin—Implications for theraphyInternational Journal of Radiation Oncology*Biology*Physics, 1986
- EFFECT OF BW12C ON OXYGEN AFFINITY OF HAEMOGLOBIN IN SICKLE-CELL DISEASEThe Lancet, 1986
- The effects in volunteers of BW12C, a compound designed to left‐shift the blood‐oxygen saturation curve.British Journal of Clinical Pharmacology, 1985
- Substituted benzaldehydes designed to increase the oxygen affinity of human haemoglobin and inhibit the sickling of sickle erythrocytesBritish Journal of Pharmacology, 1984